Literature DB >> 16823325

Endovascular reconstruction with the Neuroform stent as monotherapy for the treatment of uncoilable intradural pseudoaneurysms.

David Fiorella1, Felipe C Albuquerque, Vivek R Deshmukh, Henry H Woo, Peter A Rasmussen, Thomas J Masaryk, Cameron G McDougall.   

Abstract

OBJECTIVE: Intradural pseudoaneurysms have a malignant natural history and can be difficult to treat if parent vessel deconstruction is not feasible. These lesions often involve a long arterial segment and lack a defined saccular component that would safely accommodate the introduction of embolization coils. The current report describes the successful endovascular treatment of these lesions using a strategy of Neuroform stent reconstruction.
METHODS: A retrospective review of the prospectively maintained Neuroform databases from our two institutions identified all intracranial aneurysms treated with the Neuroform stent alone, without embolization coils. The clinical charts, procedural data, and angiographic results were reviewed.
RESULTS: Over a 38-month study period (10/02-2/06), 266 aneurysms were treated with the Neuroform stent. Of these, 10 were small "uncoilable" intradural pseudoaneurysms associated with subarachnoid hemorrhage. These lesions were treated using a strategy of endovascular stent reconstruction of the diseased vascular segment with one or more Neuroform stents (without concomitant coil embolization). Seven pseudoaneurysms were treated in the context of acute or subacute subarachnoid hemorrhage, and three were associated with a remote history of subarachnoid hemorrhage. Periprocedural complications occurred in two patients (clinically silent, intraprocedural thromboembolic event successfully treated with intra-arterial abciximab, symptomatic postprocedural stent thrombosis with successful thrombolysis, and excellent neurological recovery). Both complications occurred in patients with ruptured aneurysms and could be attributed to inadequate platelet inhibition at the time of the initial procedure. Follow-up conventional angiographic examinations were available for all 10 patients with pseudoaneurysms (1-18.5 mo; average, 9.0 mo). In nine cases, the aneurysms improved at follow-up, with either complete (n = 5) or near complete (n = 4) resolution. In one case, short-term follow-up (1 mo) demonstrated no significant change. No patient has rehemorrhaged after treatment.
CONCLUSION: Endovascular Neuroform stent reconstruction represents an optimal strategy for the management of intradural pseudoaneurysms that require a constructive treatment strategy and are too small to accommodate the introduction of embolization coils. Nine out of 10 patients in the current series treated with this strategy demonstrated some degree of endovascular remodeling with either complete (n = 5) or partial (n = 4) angiographic resolution at follow-up. No rehemorrhages were encountered. Adequate antiplatelet therapy, even in the setting of acute subarachnoid hemorrhage, is prerequisite for the avoidance of thromboembolic complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823325     DOI: 10.1227/01.NEU.0000223650.11954.6C

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  67 in total

1.  Evaluation of stent visibility by flat panel detector CT in patients treated for intracranial aneurysms.

Authors:  Frédéric Clarençon; Michel Piotin; Silvia Pistocchi; Drazenko Babic; Raphaël Blanc
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

2.  Follow-up of endovascular treatment of direct carotid-cavernous fistulas.

Authors:  Márcio C Pedro Marques; José Guilherme M Pereira Caldas; Dárcio R Nalli; Jose Roberto F Fonseca; Roberto G Nogueira; Nitamar Abdala
Journal:  Neuroradiology       Date:  2010-05-12       Impact factor: 2.804

Review 3.  Alteration of intra-aneurysmal hemodynamics for flow diversion using enterprise and vision stents.

Authors:  Markus Tremmel; Jianping Xiang; Sabareesh K Natarajan; L Nelson Hopkins; Adnan H Siddiqui; Elad I Levy; Hui Meng
Journal:  World Neurosurg       Date:  2010 Aug-Sep       Impact factor: 2.104

4.  Staged treatment of a blood blister-like aneurysm with stent-assisted coiling followed by flow diverter in-stent insertion. A case report.

Authors:  C Princiotta; M Dall'olio; L Cirillo; M Leonardi
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

5.  Acute endovascular treatment (< 48 hours) of uncoilable ruptured aneurysms at non-branching sites using silk flow-diverting devices.

Authors:  F Causin; R Pascarella; G Pavesi; R Marasco; G Zambon; R Battaglia; M Munari
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

6.  LEO Baby Stent Use following Balloon-Assisted Coiling: Single- and Dual-Stent Technique--Immediate and Midterm Results of 29 Consecutive Patients.

Authors:  P Machi; V Costalat; K Lobotesis; C Ruiz; Y B Cheikh; O Eker; G Gascou; F Danière; C Riquelme; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

7.  Evaluation of a second-generation self-expanding variable-porosity flow diverter in a rabbit elastase aneurysm model.

Authors:  C N Ionita; S K Natarajan; W Wang; L N Hopkins; E I Levy; A H Siddiqui; D R Bednarek; S Rudin
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

8.  Pipeline endovascular reconstruction of traumatic dissecting aneurysms of the intracranial internal carotid artery.

Authors:  Vikram Prasad; Dheeraj Gandhi; Gaurav Jindal
Journal:  BMJ Case Rep       Date:  2013-12-12

9.  Super-selective coil embolization of a basilar perforator artery aneurysm previously treated by the stent-in-stent technique, using an extremely soft bare coil delivered through a one-marker microcatheter.

Authors:  Yves Chau; Marina Sachet; Jacques Sédat
Journal:  Interv Neuroradiol       Date:  2017-07-20       Impact factor: 1.610

10.  Sole stenting with large cell stents for very small ruptured intracranial aneurysms.

Authors:  Young-Joon Kim; Jung Ho Ko
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.